Defiance Nasdaq Junior Biotechnology ETF
IBBJ
IBBJ was delisted on the 2nd of December, 2021.
9 hedge funds and large institutions have $761K invested in Defiance Nasdaq Junior Biotechnology ETF in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 6 → 9 (+3)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
36% less capital invested
Capital invested by funds: $1.19M → $761K (-$433K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RWB
RMR Wealth Builders
Montclair,
New Jersey
|
+$39.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$35.8K |
| 3 |
MF
Manchester Financial
Westlake Village,
California
|
+$15.6K |
| 4 |
AA
AlphaMark Advisors
Ft. Wright,
Kentucky
|
+$14.5K |
| 5 |
IF
Ironwood Financial
Tucson,
Arizona
|
+$9.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$527K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$14.3K |
| 3 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$4.72K |
IBBJ Hedge Fund Activity: Q1 2021 in Review
9 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Defiance Nasdaq Junior Biotechnology ETF (IBBJ) for Q1 2021, worth a combined $761K — down 36% from $1.19M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IBBJ positions and 0 closed out — a net gain of 3 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was RMR Wealth Builders, adding an estimated $39.9K. The largest seller was Tower Research Capital (TRC), cutting an estimated $527K.
- 9 institutional investors held Defiance Nasdaq Junior Biotechnology ETF (IBBJ) as of Q1 2021, up from 6 in Q4 2020.
- Funds reported $761K of Defiance Nasdaq Junior Biotechnology ETF stock for Q1 2021, down 36% quarter-over-quarter.
- 3 funds opened new Defiance Nasdaq Junior Biotechnology ETF positions in Q1 2021 and 0 closed out, a net change of +3 holders.
- The largest Defiance Nasdaq Junior Biotechnology ETF buyer in Q1 2021 was RMR Wealth Builders, an estimated $39.9K added.
- The largest Defiance Nasdaq Junior Biotechnology ETF seller in Q1 2021 was Tower Research Capital (TRC), an estimated $527K sold.
Based on aggregated 13F filings for Q1 2021.